Literature DB >> 28042536

Central Nodes in Protein Interaction Networks Drive Critical Functions in Transforming Growth Factor Beta-1 Stimulated Kidney Cells.

Reyhaneh Rabieian1, Maryam Abedi1, Yousof Gheisari1,2.   

Abstract

OBJECTIVE: Despite the huge efforts, chronic kidney disease (CKD) remains as an unsolved problem in medicine. Many studies have shown a central role for transforming growth factor beta-1 (TGFβ-1) and its downstream signaling cascades in the pathogenesis of CKD. In this study, we have reanalyzed a microarray dataset to recognize critical signaling pathways controlled by TGFβ-1.
MATERIALS AND METHODS: This study is a bioinformatics reanalysis for a microarray data. The GSE23338 dataset was downloaded from the gene expression omnibus (GEO) database which assesses the mRNA expression profile of TGFβ-1 treated human kidney cells after 24 and 48 hours incubation. The protein interaction networks for differentially expressed (DE) genes in both time points were constructed and enriched. In addition, by network topology analysis, genes with high centrality were identified and then pathway enrichment analysis was performed with either the total network genes or with the central nodes.
RESULTS: We found 110 and 170 genes differentially expressed in the time points 24 and 48 hours, respectively. As the genes in each time point had few interactions, the networks were enriched by adding previously known genes interacting with the differentially expressed ones. In terms of degree, betweenness, and closeness centrality parameters 62 and 60 nodes were considered to be central in the enriched networks of 24 hours and 48 hours treatment, respectively. Pathway enrichment analysis with the central nodes was more informative than those with all network nodes or even initial DE genes, revealing key signaling pathways.
CONCLUSION: We here introduced a method for the analysis of microarray data that integrates the expression pattern of genes with their topological properties in protein interaction networks. This holistic novel approach allows extracting knowledge from raw bulk omics data.

Entities:  

Keywords:  Chronic Kidney Disease; Microarray Analysis; Protein Interaction Maps; Systems Biology; Transforming Growth Factor Beta-1

Year:  2016        PMID: 28042536      PMCID: PMC5086330          DOI: 10.22074/cellj.2016.4718

Source DB:  PubMed          Journal:  Cell J        ISSN: 2228-5806            Impact factor:   2.479


Introduction

Chronic kidney disease (CKD) is a public health problem and a leading cause of death. Despite using current therapies to slow progression of CKD, respective patients are still reaching the end stage renal disease (ESRD) at alarming proportions (1). The histological feature of this debilitating disorder is excessive deposition of extra-cellular matrix (ECM) defined as renal fibrosis. Recent studies declared that transforming growth factor beta-1 (TGFβ-1) is the major driver of fibrosis in kidney, stimulating a variety of signaling pathways related to deposition of ECM components (2). In spite of enormous researches on the role of TGFβ-1 and downstream elements in the progression of CKD (3, 4), few studies have employed holistic and computational methods for investigation of kidney disorders. Among these studies, there is an elegant report presented by Jin et al. (5) who employed gene regulatory network concepts to analyze high-throughput gene expression data. They could predict and experimentally validate HIPK2 as a potential drug target in HIV-associated nephropathy. Here, we propose a holistic approach to investigate the molecular interactions and signaling pathways in response to TGFβ-1 stimulation in human kidney cells. A microarray dataset has been generated by Walsh et al. (6) that examines the expression profile of human tubular epithelial cells before and after treatment with TGFβ-1 for 24 and 48 hours. However, they only focused on the few top differentially expressed (DE) genes including GREM1, JAG1 and HES1. They identified Notch signaling as a critical pathway in diabetic nephropathy. In the current study, we introduced a new method for the analysis of the same microarray dataset that integrated the expression pattern of genes with their topological location in the gene interaction network. Using this strategy, we could infer more informative signaling pathways related to TGFβ-1 stimulation. This approach could also be employed for other large data to improve our understanding of biological processes by extracting remarkable concepts from bulk omics data.

Materials and Methods

Microarray data

This study is a bioinformatics analysis of GSE23338 dataset, originally generated by Walsh et al. (6). mRNA expression profile was downloaded from the Gene Expression Omnibus (GEO) database (7). In this microarray experiment, transcriptional response of human proximal tubule epithelial cells (HK-2) to TGFβ-1 stimulation after 24 and 48 hours was assessed. Using GEO2R tool of GEO, the TGFβ-1 treated cells (24 or 48 hours) were compared to untreated HK-2 cells. Benjamini-Hochberg false discovery rate method was applied for P value adjustment. Genes with adjusted P≤0.05 were considered as differentially expressed.

Protein-protein interaction network

Using CluePedia plugin (8) of the Cytoscape software version 3.1.0 (9), a protein-protein interaction (PPI) network was constructed for the DE genes in time point of 24 hours or 48 hours. Topology of networks was analyzed by the NetworkAnalyzer tool of Cytoscape software.

Pathway enrichment analysis

Pathway enrichment analysis for DE genes was carried out using ClueGO plugin (10) of Cytoscape. In this analysis, KEGG and Reactome databases were chosen for retrieving data and network specificity was adjusted to medium. Bonferroni step down was applied for P value adjustment and pathways with adjusted P≤0.05 were chosen.

Results

In this study, we reanalyzed the GSE23338 microarray dataset assessing mRNA expression profile of HK-2 cells after 24 and 48 hours of treatment with TGFβ-1. Analysis by GEO2R revealed that 110 genes after 24 hours and 170 genes after 48 hours were differentially expressed with adjusted P≤0.05 (Table 1). To investigate the interaction between variably expressed genes, a network was constructed for each time point. Although different kind of interactions (activation, post-translational modification, expression and binding) were allowed to be shown, unexpectedly, few interactions were appeared in both networks (Fig .1A, B). To infer pathways related to the DE genes and understand the down-stream processes controlled by TGFβ-1, pathway enrichment analysis was performed, showing only 12 pathways for 24 hours (Fig .1C) and 10 pathways for 48 hours treatments (Fig .1D), with few connections between the signaling pathways.
Table 1

Differentially expressed genes in time 24 hours and 48 hours with adjusted P≤0.05. The genes are sorted by log2 of fold change (LogFC)


Time 24Time 48
Genesadj.P.VallogFCGenesadj.P.VallogFC

GDF150.012817 -4.03492GDF150.004294 -3.77276
CRYM0.046546-3.35307CRYM0.020195 -3.74094
SCNN1A0.012817-3.19552CD90.000557-3.3273
CD90.003455-2.96886 SCNN1A0.006484-2.86473
RBM470.012817-2.96538RBM470.010066 -2.73215
MAL0.012817-2.6579MAL0.007941-2.72193
HLF0.033274-2.44538AREG0.014332-2.71598
DEPTOR0.011983-2.38064HLF0.021497-2.52256
IMPA20.002857-2.22728 PLA1A0.007423-2.46499
RTEL10.003588-2.11992 PDZK1IP10.026161-2.45799
MEGF90.03429 -2.04315DUSP50.005251-2.37922
GSE10.011894-2.04015ACSL10.003583-2.36964
ELOVL60.004534-2.02884DEPTOR0.014818-2.23285
BIRC30.012817-1.98537DEFB10.001178-2.1258
SLC17A30.006063-1.96502IMPA20.001964-2.11942
SULT1C20.045879-1.93073HLA-DMB0.036113-2.11004
DUSP60.018789-1.93001FXYD20.002471-2.09686
CEBPD0.015951-1.89181RTEL10.003148-1.99502
DEFB1 0.003455-1.87388CLDN10.002102-1.9428
ACSL10.003455-1.84878BIRC30.008587-1.93307
PLA1A0.030906-1.79724SULT1C20.028474-1.89456
DUSP50.011894-1.78577FAS 0.040775-1.84699
CA120.011983-1.70822CEBPD0.014469-1.81201
CLDN10.006732-1.69617SLC17A30.010066-1.78837
PDZK1IP10.031449-1.66723LY6E0.003332-1.70064
ADAMTS30.009793-1.64873SERPINA10.021497-1.68148
CDKN2AIP0.047829 -1.62696SLCO4A10.03808-1.67053
GULP10.049153-1.55674SOD20.003686-1.65771
ACVR1B0.019538-1.47953TSPAN10.011747-1.65484
ID20.018571-1.45204PLIN20.026161-1.62099
EPAS10.049153 -1.42294MEGF90.024224-1.61932
SOD20.016073-1.41158RAB200.026161-1.59433
ANXA40.047613-1.37096CLU0.002471 -1.54936
RAB200.015265-1.34593SLC4A4 0.03487-1.50061
MMD0.030004-1.33753GULP10.047026 -1.46306
CLU0.01997 -1.32415EPAS10.038561-1.42677
BDNF0.018571-1.26903ACVR1B0.013621-1.3911
EPCAM0.015265-1.26628GPRC5C0.026161-1.34555
NR2F20.044918-1.26334GSE1 0.041643-1.32532
TMEM1590.047829 -1.25784LRRC610.020785-1.32277
FAS0.019538-1.23999ANXA40.038789-1.31199
LY6E0.014942-1.20673CDKN2AIP0.03949-1.30584
LRRC610.033972-1.17462MMD0.021485-1.29784
PPP2R5A0.023781-1.16917PPP2R5A0.019989-1.25554
SERPINA10.039821-1.09323NR2F20.012081-1.22902
IL240.011983-1.09102GLRX0.035692-1.22902
HGD0.019538-1.08015SERPINA60.00653-1.22661
ELF30.026977-1.07437EMP10.030041-1.22491
GCH10.032261-1.0672MAPKAPK30.037211-1.20559
ALDH5A10.030004-1.05748IFI300.039032-1.1775
FXYD20.020961-1.02587 EPCAM0.014332-1.17347
TRIM380.043165-0.92721SYS1-DBNDD20.039499-1.16256
NHLRC20.018571-0.92091 ADAMTS30.014586-1.12871
TBL1X0.040887 -0.88595SHMT10.036579-1.12397
LAD10.04193-0.87726GGT20.007492 -1.10696
GLRX0.035216-0.87251LAD10.014332-1.09515
TPM10.030916 0.782848FOSL10.023626 -1.08872
AMIGO20.0322610.803279 ELF30.022045-1.078
MISP0.0309160.808838ID20.03219 -1.07757
ACLY0.0307780.809032SMAD30.042933-1.05481
FN10.034290.860918IL240.030041-1.03178
LYPD10.0469550.922314SH2B20.020195-1.00971
RALA0.030004 0.95394DUSP60.038561 -0.98235
EFNB20.0300040.9589 ITPR30.021485-0.9804
SMURF20.0447721.000129PDLIM10.044481-0.96321
TFPI20.0195381.042945 ALDH5A10.019989-0.95377
MARCH30.0260131.048251FAM3C0.039499 -0.93464
NREP0.0314491.121914REPIN10.038561-0.9095
LTBP20.0152651.133197GGT10.036579-0.893
PLEK20.0251431.137329ANXA10.03141-0.8635
RFTN10.0147681.141252UXS10.037211-0.78881
PRPS10.0212431.212761HGD0.039499-0.77866
ADA0.0128171.214286TBL1X0.028029 -0.76181
TNS1 0.0270641.276677MGLL0.039499-0.75719
COL1A10.0449181.349036GNPDA10.028029-0.75096
LAMC20.0152651.448205PAX80.031546-0.73263
CREB3L10.0044251.453935TRIM380.026161-0.69388
TSPAN130.0309161.468138PROSC0.047627-0.68991
F30.0498541.537792TPM10.0455420.614444
AKAP120.0300041.541307ARL4C0.0385610.67729
HES10.0152651.549119IFNGR2 0.0455420.695846
SGK10.0060631.584326RFTN10.0378890.727815
PAX60.0147681.602106ACLY0.0214850.74412
GREM10.0048181.607941EFNB20.0264860.789092
PTHLH0.0185711.651867CLTCL10.0437480.805174
SLN0.0309161.66995SMURF20.0199890.813175
ADAM190.0469551.673182FAM208B0.0385610.815648
TUFT10.019971.708363TPM40.0365790.816674
PPP1R13L0.0446221.715701PLEK20.0406070.838742
VEGFC0.0067321.731189FHOD30.0437480.840283
GPR560.0052221.757315CADM10.0148180.842324
LRP40.0067321.839036DLC10.0356920.861077
SIK10.0284311.847404ELK30.0372110.866603
C1orf1060.0147681.852771AMIGO20.013633 0.891177
KCNK30.0198911.928548PGRMC20.0385610.892116
WNT5B0.0152651.950651RAB320.0394990.911187
SNAI20.0213561.996987UAP10.029660.914231
GALNT100.0227352.016561SKIL0.0378890.927445
GADD45B0.0052222.081882MAGED20.0474660.933606
FSTL30.0068712.18737DYRK20.0455420.941228
WNT5A0.0152652.199978PALLD0.0394990.960395
SCG50.0060632.421762MKL10.0120810.986708
TGFBI0.0100682.585222 MARCH30.039989 1.008954
TP53I30.0185712.591672 LTBP20.0074231.013795
IL110.006063 2.680544GABARAPL10.026161 1.018263
PMEPA10.002821 2.69133TFPI20.0455421.023787
TAGLN0.015265 2.807473NOV0.03219 1.037359
SLCO2A10.002821 2.969782 NUAK10.0109621.041704
INHBA0.006732 3.742935SLC22A40.0217011.057375
JAG10.012993 4.819474 PDLIM70.0365791.075928
SEMA3C0.0402141.084533
PRPS10.0189331.090259
COL4A10.014469 1.103866
NREP0.0138841.110733
LYPD10.0284741.112816
TCF40.0440161.140686
GADD45B0.0476271.201497
INPP4B0.0035831.212552
SGK10.0105941.225169
IL150.0365791.22672
MAP3K40.0289441.263727
TUFT10.0372111.284833
SPARC0.0199891.288601
COL7A10.006531.297757
ADAM120.008731 1.356895
CREB3L10.003148 1.386727
PTHLH0.0131011.415775
ADAM190.026161 1.427201
IGF1R0.0470261.47119
ARHGEF400.010871.471459
WNT5B0.0378891.474394
C1orf1060.0186961.482021
FSTL30.0106211.530293
LRP40.019989 1.533742
NEDD90.040607 1.541275
HES10.0199891.573046
SPOCK10.0145861.577949
TSPAN130.0148181.599124
SPHK10.0241131.599544
THBS10.0478721.633499
BCAT10.0033321.666823
AKAP120.0100661.677861
SLN0.0157451.68979
DSP0.0483481.726407
FN10.0049081.832317
SCG50.0008151.864837
GPR560.0109621.900793
GALNT100.0286121.917703
PAX60.0052511.918114
GREM10.0016441.934697
SIK10.0120811.972459
TP53I30.0357871.979721
VEGFC0.0106211.991006
EFEMP10.0075162.118009
SLC26A20.0263572.161277
FBN10.0199892.339046
WNT5A0.0013542.385963
MMP130.0247322.392553
TAGLN0.0100662.43914
SNAI20.0024712.45019
PMEPA10.0008152.475717
TNS10.0120812.514322
TGFBI0.0024712.622322
IL110.0019642.698275
SLCO2A10.0011452.774921
SLC7A110.002263.076526
MMP10.0219733.220728
SERPINE10.0008153.452134
INHBA0.0008153.757617
JAG10.0075164.928316

Fig.1

Interaction networks of the DE genes in the microarray dataset were poor and few signaling pathways were enriched. The expression profiles of human kidney cells treated with TGFβ-1 for 24 or 48 hours were compared to untreated cells. The interaction networks of the differentially expressed genes in the time points of A. 24 hours and B. 48 hours have few edges. In addition, pathway enrichment analysis of these genes in C. 24 hours and D. 48 hours could not detect key signaling pathways. Pathways with adjusted P≤0.05 are shown. Color represents the gene ontology (GO) term level.

TGFβ-1; Transforming growth factor Beta-1 and DE; Differentially expressed.

The scarcity of interactions in PPI and pathway networks was not unexpected, as they were derived from mRNA microarray data which can only detect genes with altered mRNA level, thus regulated genes at other levels were missed. Hence, to predict other role players, we enriched both PPI networks by adding one interacting node for each gene. This resulted in expansion from 110 to 199 nodes for 24 hours (Fig .2A) and from 170 to 301 nodes for 48 hours treatment (Fig .2B). PPI networks were reconstructed with the same parameters applied initially. To determine the most central genes in these enriched networks, their topology was assessed by graph theory measures such as degree, betweenness centrality, and closeness centrality. In each network, the genes were sorted based on each of these features. Then, the top 20% genes in 24 hours treatment and 15% genes with higher rank in 48 hours were chosen. Because of overlapping nodes between the above three centrality parameters, a total of 62 genes in time point of 24 hours (Table 2) and 60 genes in time point of 48 hours (Table 3) were finally selected. Again, pathway enrichment analysis was performed with either the central genes or the total genes in these two enriched networks. The central genes in time points 24 and 48 hours networks were related to 29 and 49 pathways, respectively (Fig .3). These pathways were strongly related to CKD and formed a deeply connected network in both time points. Interestingly, pathway enrichment analysis with the total enriched networks genes, only determined 16 and 18 pathways for time points of 24 and 48 hours, respectively. These pathways were less inter-connected compared to those derived from the central genes (Fig .4).
Fig.2

Enrichment of the protein-protein interaction (PPI) network is an efficient method to predict the missed interacting nodes. The networks of A. 24 hours and B. 48 hours treatment were enriched. The selected nodes from microarray experiment are depicted with ellipse and enriched nodes with triangle.

Table 2

The top 20% genes with the best rank in degree, betweenness centrality, and closeness centrality parameters in the enriched proteinprotein interaction (PPI) network of time 24 hours


GeansDegreeGeansBetweennessGeansCloseness

TP5335TP530.338181TP530.397906
FN116MMP20.171374MMP20.38191
CTNNB115ALB0.145517NOTCH10.361045
MMP215CTNNB10.125341ALB0.356808
ALB14NOTCH10.11946AR0.35023
AR14SERPINE10.100643CTNNB10.347032
NOTCH114AR0.085536SERPINE10.344671
SHH13FN10.075905SMAD20.334802
SMAD211SHH0.069747FN10.333333
SERPINE110SMAD20.069443ACVR1B0.326882
COL1A19PRKAR2A0.067309ACVR2A0.326882
PRKAR2A9HSPA50.067049SHH0.325482
MAPK19MAP3K50.049224CD90.324094
TGFBI8PTHLH0.047677MAPK10.319328
ACVR1B8HRAS0.045799NCOR10.316667
IFNG8TGFBI0.044403LAMC20.31405
TCF48HNF1B0.040631VTN0.312115
ACVR2A8CDKN2A0.039982FAS0.310838
FAS7NCOR10.039374TCF40.310204
BDNF7PAX60.038418SOD20.308943
CD96CD90.038417CTBP10.307692
LAMC26TCF40.037912PAX60.306452
CTBP16NR0B10.035918HES10.306452
PAX66FAS0.035234HSPA50.305835
HES16MAPK10.031996IFNG0.305221
CSF26NEDD4L0.030261KDM1A0.305221
NR0B16SLC9A3R20.028821TGFBI0.304609
HNF1B6IFNG0.028734CSF20.304609
LRP26CSF20.027151PRKAR2A0.304
TRAF26ANXA20.026874DECR10.303393
RIPK16PROC0.026277PPP2R1A0.302187
NCOR15KDR0.024832DECR10.303393
VTN5CTBP10.024626PPP2R1A0.302187
SOD25APOB0.024534COL1A10.30099
HSPA55TRAF20.024347BDNF0.298625
CDKN2A5F30.022625TDGF10.295146
HRAS5BDNF0.022597F70.294574
CYP7A15LRP20.022317NR0B10.293436
KDR5COL2A10.022231HNF1B0.292308
ID25GSTA10.021794CDKN2A0.291747
MAP3K55VTN0.021145DUSP50.290631
CLU5ARF60.020175LRP20.290076
NEDD4L5YWHAB0.01996ANXA20.289524
FST5ACVR1B0.018667F30.288425
MSTN5ACVR2A0.018667PTHLH0.287335
PROC5RALA0.018621HRAS0.286792

Table 3

The top 15% genes with the best rank in degree, betweenness centrality, and closeness centrality parameters in the enriched proteinprotein interaction (PPI) network of time 48 hours


GenesDegreeGenesBetweennessGenesCloseness

TP5355TP530.218425JUN0.419966
AKT149AKT10.180618TP530.419244
EGFR33EGFR0.129406AKT10.415673
SMAD332JUN0.121849EGFR0.403974
JUN32SMAD30.091028AR0.403306
AR28ALB0.08664SMAD30.394184
FN125CTNNB10.077284CTNNB10.3904
THBS124AR0.063727SMAD40.387917
CTNNB123SMAD40.059499SERPINE10.387917
SMAD223FN10.056896NOTCH10.380655
SERPINE120THBS10.049411THBS10.377709
SMAD420SHH0.0474SMAD20.375963
NOTCH118NOTCH10.044617FN10.371951
ALB16SERPINE10.041249MMP10.369138
SHH16STAT10.039746MAPK10.365269
PLG15HSPA50.037599STAT10.364179
MMP114PLG0.035914MMP130.359882
TCF413TRAF20.035805ALB0.357247
TGFBI12PRKAR2A0.03185IGF1R0.357247
MAPK112SMAD20.028572ACVR1B0.350575
ACVR1B11SLC9A3R20.028142ACVR2A0.350575
CSF211HSPD10.027604CSF20.34907
PRKAR2A11HRAS0.025499KDR0.348074
STAT111TCF40.024472CDK10.348074
TRAF211PALLD0.024455CTBP10.347578
IGF1R10TGFBI0.024427PPP2R1A0.346591
CDKN2A10STX20.024388SHH0.343662
MAP3K510CDKN2A0.022895SPOCK10.343662
ACVR2A10CD90.021863GRB100.343179
ID29NCOR10.021568NOV0.342216
MMP139MAP3K50.020279GSTA10.33936
SKIL9HNF1B0.020242TCF40.338889
SPOCK19SPOCK10.018718FAS0.336088
PDLIM79CTBP10.018114CDKN2A0.335626
KDR9TPM10.018056NCOR10.335626
LRP29PTHLH0.017657TGFBI0.335165
TCF39TBL1X0.016927VCAN0.334705
NOV8CSF20.015788HSPA50.334247
PTHLH8GSTA10.015304CLTCL10.333333
CDKN1B8KDR0.015185SKIL0.333333
GADD45A8MMP130.014604PLG0.332879
GRB108ANXA20.01411PTHLH0.332879
LAMA58CLTCL10.013602PRKAR2A0.332425
VTN8MAPK10.012772MAP3K50.330623
CBL8TCF30.012502LAMA50.330176

Fig.3

Selection of central nodes for pathway enrichment analysis can detect critical signaling pathways. In the enriched protein-protein interaction (PPI) networks, 62 genes for 24 hours treatment network and 60 genes for 48 hours treatment network were chosen as nodes with high cen trality. These central nodes are related to 29 and 49 highly c onnected pathways in A. 24 hours and B. 48 hours, respectively. Pathways with adjusted P≤0.05 are shown. Color represents the gene ontology (GO) term level.

Fig.4

Pathway enrichment analysis with total genes in the enriched network is not informative. Pathway enrichment analysis with all 199 genes in 24 hours, or 301 genes in 48 hours treatment in enriched PPI networks only demonstrated A. 16 or B. 18 poorly inter-connected pathways, respectively. Pathways with adjusted P≤0.05 are shown. Color represents the gene ontology (GO) term level.

Pathway enrichment analysis with the central genes predicted Notch, TNF, P53, Activin and TGFβ signaling as well as platelet-related pathways, affected after TGFβ-1 treatment in both 24 and 48 hours. However, Hippo, PDGF and FGFR signaling pathways were enriched only in the second time point. Differentially expressed genes in time 24 hours and 48 hours with adjusted P≤0.05. The genes are sorted by log2 of fold change (LogFC) Interaction networks of the DE genes in the microarray dataset were poor and few signaling pathways were enriched. The expression profiles of human kidney cells treated with TGFβ-1 for 24 or 48 hours were compared to untreated cells. The interaction networks of the differentially expressed genes in the time points of A. 24 hours and B. 48 hours have few edges. In addition, pathway enrichment analysis of these genes in C. 24 hours and D. 48 hours could not detect key signaling pathways. Pathways with adjusted P≤0.05 are shown. Color represents the gene ontology (GO) term level. TGFβ-1; Transforming growth factor Beta-1 and DE; Differentially expressed. Enrichment of the protein-protein interaction (PPI) network is an efficient method to predict the missed interacting nodes. The networks of A. 24 hours and B. 48 hours treatment were enriched. The selected nodes from microarray experiment are depicted with ellipse and enriched nodes with triangle. The top 20% genes with the best rank in degree, betweenness centrality, and closeness centrality parameters in the enriched proteinprotein interaction (PPI) network of time 24 hours The top 15% genes with the best rank in degree, betweenness centrality, and closeness centrality parameters in the enriched proteinprotein interaction (PPI) network of time 48 hours Selection of central nodes for pathway enrichment analysis can detect critical signaling pathways. In the enriched protein-protein interaction (PPI) networks, 62 genes for 24 hours treatment network and 60 genes for 48 hours treatment network were chosen as nodes with high cen trality. These central nodes are related to 29 and 49 highly c onnected pathways in A. 24 hours and B. 48 hours, respectively. Pathways with adjusted P≤0.05 are shown. Color represents the gene ontology (GO) term level. Pathway enrichment analysis with total genes in the enriched network is not informative. Pathway enrichment analysis with all 199 genes in 24 hours, or 301 genes in 48 hours treatment in enriched PPI networks only demonstrated A. 16 or B. 18 poorly inter-connected pathways, respectively. Pathways with adjusted P≤0.05 are shown. Color represents the gene ontology (GO) term level.

Discussion

In this study, we reanalyzed a microarray dataset to determine gene expression alteration in response to TGFβ-1 in a human kidney cell line. The investigators who originally generated this data emphasized the involvement of Notch signaling pathway based on a few DE genes (6). In contrast, we have constructed PPI networks for DE genes in the time points of 24 and 48 hours treatment. We found that expansion of these networks followed by selection of central nodes for pathway enrichment analysis is an efficient method to recognize key signaling pathways in response to TGFβ-1 stimulation. Our analysis also predicted the potential role of some novel pathways in this in vitro model and also pointed out time-dependent activation of particular pathways. Interestingly, the same investigators later repeated the experiment and assessed the mRNA expression profile by RNA-Seq and found that this technique is superior to microarray in identification of the DE genes and altered signaling pathways (11). Noteworthy, the signaling pathways determined by our analysis on the original microarray dataset is similar to the pathways identified with RNA-Seq data. An interesting finding in this study was that pathway enrichment analysis with the DE genes in the microarray experiment was not efficient for prediction of key signaling pathways. However, it was expected that all important genes were not regulated at the mRNA level and so they were not detectable by mRNA microarrays. Therefore, to compensate for this limitation, we constructed a PPI network of DE genes and then enriched this network by adding genes that were previously known to be interacting with the initial network nodes. This expanded gene set was more informative for detecting signaling pathways. Indeed, it is perfect to perform multi-level assessments in biological experiments, but for practical reasons it is not commonly feasible. In this case, it is possible to measure changes at one level and then make bioinformatics predictions to fill the gaps at other levels. Several previous studies have shown that highly connected nodes (hubs) in the networks, determined by degree parameter, are vital for the organism survival (12). Next studies revealed that essential genes in the network can be determined not only by degree but also by other centrality parameters, such as betweenness or closeness centrality (13,14). Here, we have used a combination of these three network topology parameters to determine the central nodes. Interestingly, pathway enrichment with these central genes was more informative than enrichment with the initial genes or even with the total genes in the expanded PPI networks. This observation is in line with our recent study on diabetic nephropathy showing the central network nodes tend to be present in signaling pathways and cross talks (15). In pathway enrichment analysis, Hippo, PDGF, and FGFR signaling pathways were detected only in the second time point, 48 hours treatment. Actually, the initial activation of upstream signaling pathways detected in 24 hours treatment may lead to the expression of genes, related to these three pathways after 48 hours. This finding on time-specific expression of genes underscores the importance of time-course designs for gene expression analysis experiments. Most of the predicted pathways in our analysis such as Notch, TNF, P53, and TGFβ signaling have been previously known to be involved in the pathogenesis of CKD (16,19), whereas, for some others, such as platelet degranulation pathway, there is not currently direct experimental proof for participation in renal fibrosis. However, previous experiments have shown megakaryocytes as mediators of fibrosis in a subset of hematologic malignancies, idiopathic pulmonary fibrosis, as well as bone marrow (20,22). The role of megakaryocytes in kidney fibrosis is an interesting topic for future studies.

Conclusion

We have here employed a holistic approach to assess the consequences of TGFβ-1 stimulation in kidney cells. Although, high-throughput techniques are frequently applied in biological investigations, data interpretation is yet commonly limited to the assessment of most up or down-regulated factors missing the huge effect of interactions for genes with subtle expression change. Systems biology provides novel concepts and methods to infer the underlying mechanisms of biological phenomena from omics raw data and hopefully will bring a higher quality of life to those suffering from chronic diseases.
  22 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  The organisational structure of protein networks: revisiting the centrality-lethality hypothesis.

Authors:  Karthik Raman; Nandita Damaraju; Govind Krishna Joshi
Journal:  Syst Synth Biol       Date:  2013-08-27

Review 3.  Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection.

Authors:  Nikolaos Papadantonakis; Shinobu Matsuura; Katya Ravid
Journal:  Blood       Date:  2012-07-05       Impact factor: 22.113

4.  Co-regulation of Gremlin and Notch signalling in diabetic nephropathy.

Authors:  David W Walsh; Sarah A Roxburgh; Paul McGettigan; Celine C Berthier; Desmond G Higgins; Matthias Kretzler; Clemens D Cohen; Sergio Mezzano; Derek P Brazil; Finian Martin
Journal:  Biochim Biophys Acta       Date:  2007-10-11

5.  The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis.

Authors:  Jecko Thachil
Journal:  Med Hypotheses       Date:  2008-11-25       Impact factor: 1.538

Review 6.  TGF-beta in renal injury and disease.

Authors:  Erwin P Böttinger
Journal:  Semin Nephrol       Date:  2007-05       Impact factor: 5.299

Review 7.  Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.

Authors:  Hui Yao Lan
Journal:  Int J Biol Sci       Date:  2011-09-02       Impact factor: 6.580

8.  A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.

Authors:  Yuanmeng Jin; Krishna Ratnam; Peter Y Chuang; Ying Fan; Yifei Zhong; Yan Dai; Amin R Mazloom; Edward Y Chen; Vivette D'Agati; Huabao Xiong; Michael J Ross; Nan Chen; Avi Ma'ayan; John Cijiang He
Journal:  Nat Med       Date:  2012-03-11       Impact factor: 53.440

9.  Why do hubs tend to be essential in protein networks?

Authors:  Xionglei He; Jianzhi Zhang
Journal:  PLoS Genet       Date:  2006-04-26       Impact factor: 5.917

10.  Nodes with high centrality in protein interaction networks are responsible for driving signaling pathways in diabetic nephropathy.

Authors:  Maryam Abedi; Yousof Gheisari
Journal:  PeerJ       Date:  2015-10-01       Impact factor: 2.984

View more
  4 in total

1.  Low-Level Laser Therapy Effects on Rat Blood Hemostasis Via Significant Alteration in Fibrinogen and Plasminogen Expression Level.

Authors:  Babak Arjmand; Mahmood Khodadoost; Somayeh Jahani Sherafat; Mostafa Rezaei Tavirani; Nayebali Ahmadi; Farshad Okhovatian; Majid Rezaei Tavirani
Journal:  J Lasers Med Sci       Date:  2021-10-09

2.  The analysis of a time-course transcriptome profile by systems biology approaches reveals key molecular processes in acute kidney injury.

Authors:  Kobra Moradzadeh; Yousof Gheisari
Journal:  J Res Med Sci       Date:  2019-01-31       Impact factor: 1.852

3.  A systematic integrative approach reveals novel microRNAs in diabetic nephropathy.

Authors:  Farnoush Kiyanpour; Maryam Abedi; Yousof Gheisari
Journal:  J Res Med Sci       Date:  2020-01-20       Impact factor: 1.852

Review 4.  GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease.

Authors:  Hanne Leysen; Deborah Walter; Bregje Christiaenssen; Romi Vandoren; İrem Harputluoğlu; Nore Van Loon; Stuart Maudsley
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.